SCA. 2, 3 However, the extent and mechanisms of CNS involvement remain unknown in SCA.
Activation of inflammatory and neuronal cells in the CNS plays a pivotal role in nociception. 4 We recently observed that spinal nociceptive neurons are sensitized in sickle mice suggestive of central sensitization. 5 Bidirectional signaling occurs between neurons and immunocompetent cells present in the CNS, including microglia, astrocytes and oligodendrocytes. 4 Activated microglia release reactive oxidative species (ROS), inflammatory cytokines, neurotrophic factors, and prostaglandins that excite nociceptive neurons and contribute to the persistence of chronic pain. 4 It is therefore likely that activation of central nociceptive mechanisms contributes to chronic pain in SCA.
Remarkable decrease in inflammation, thiobarbituric acid reactive substances (TBARS, an indicator of oxidative stress), and VOC have been observed in SCA patients receiving coenzyme Q10 (CoQ10). 6 Additionally, curcumin reduced markers of oxidative stress in thalassemia patients and also ameliorates pain hypersensitivity in rats with monoarthritis by decreasing spinal neuroinflammation. 7, 8 Since excess free iron due to hemolysis contributes to oxidative stress and inflammation in SCA, we examined glial activation, inflammation and oxidative stress in the spinal cords of sickle mice and tested the possibility of a synergistic effect of CoQ10 and/or curcumin to ameliorate spinal oxidative stress, glial activation and hyperalgesia.
To examine our hypotheses, we used female transgenic HbSS-BERK sickle mice with murine α and β globin knockouts and expressing human sickle, or normal haemoglobin A (designated sickle or control mice, henceforth, respectively). We bred and characterized these mice by pheno-and geno-typing (Please see Online Supplementary Appendix for details). to vehicle-treatment in sickle mice ( Figure 1 A-H). The reduction in activated astroglia was similar to that found in control mice while activated microglia remained significantly elevated after treatment as compared to control mice. Thus, curcumin and CoQ10 are both able to reduce SP and ROS expression in sickle mice, and together reduce ROS to levels seen in control mice. Microglial activation is dependent upon MAPK signalling. Previously, we observed increased phosphorylation of MAPK/ERK and p38MAPK simultaneously with nociceptor sensitization in the spinal cords of these sickle mice as compared to control mice. 5 Therefore, it is likely that glial activation contributes to spinal MAPK activation, nociceptor sensitization and chronic hyperalgesia observed in sickle mice.
Astrocyte activation is a result of calcium influx into the astrocytes, which is caused by increased blood flow. 12 Previously we observed increased blood flow in the skin of sickle mice as compared to control mice. 3 Therefore, it is likely that blood flow may be higher in the spinal cord of sickle mice, contributing to astrocytic activation observed in our studies. Astrocytes are activated by glutamate, SP and many other neurotransmitters released upon stimulation of hyperexcitable nociceptive neurons in nerve injury. In turn, activated astrocytes release these same neurotransmitters, further augmenting neuronal excitability. 4 In the setting of nerve injury or chronic neuropathic pain conditions, astrocyte activation is maintained by microglia-derived inflammatory factors. The increase in concurrent expression of ROS and SP strongly suggests a global constitutive inflammatory state and oxidative stress in the CNS, which may underlie central sensitization leading to chronic pain observed in patients with SCA and sickle mice. Of note, increased circulating levels of SP have been reported in patients with SCA as compared to normal healthy subjects 13 and in the skin and blood of sickle mice as compared to control mice. In clinical trials, curcumin was efficacious in reducing inflammation and oxidative stress and improving the outcomes in several conditions including both rheumatoid-and osteo-arthritis.
14 Short-term use of Theracurcumin with relatively higher bioavailability than curcumin was effective in reducing pain and symptoms of osteoarthritis in a randomized, double-blind, placebo-controlled prospective study for treating knee osteoarthritis. 15 In this study, 8 weeks of Theracurcumin treatment significantly reduced knee pain and lowered Celecoxib dependence as compared to placebo. Curcumin reduced oxidative stress in thalassaemia patients and decreased iron overload and oxidative stress in the liver and spleen of chronic iron-overloaded rats. 7, 16 Thus, curcumin may influence the sickle microenvironment that includes large quantities of cell-free iron due to haemolysis and oxidative stress. Treatment with curcumin and/or CoQ10 could be a promising alternative strategy to reduce pain in SCA. Considering the challenges with treating chronic sickle pain and requirements of high doses of opioids to treat pain, this approach may reduce the requirement of opioid analgesics and/or improve the outcomes of opioid analgesia.
Footnotes
For definitions, please see Table 1 
Pain Behavior Analysis
All behavioural tests were performed in a quiet room maintained at a constant temperature of 23--25°C during the proestrous/estrous cycle once a week for a total of four weeks before that day's treatment. Mice were habituated to each test protocol and environment for three consecutive days before collecting baseline measurements as described earlier. 2 Three measurements were recorded for each test, or as described, for the following behaviors. with a 2.6X electronic zoom following the protocol by Hains et al. 8 Activated microglia were classified based on the following criteria: somata exhibiting hypertrophia and retracted processes.
Three representative non--adjacent FOV from the dorsal horn were selected. For uniformity the FOV were collected from the superficial dorsal horn, superficial lateral dorsal horn and in proximity to the central canal. Each segment and the total number of glial cells in the three FOV were calculated for each group. The average of the three sections/mouse for 8 mice was averaged for each group.
Reactive oxygen species
Lumbar spinal cords sections (30 µm) were incubated with the superoxide indicator dihydroethidium (DHE; Life Technology, Grand Island, NY) at 5µM and imaged using LSCM (Olympus FluoView 1000 BX2). The percentage of fluorescence pixels divided by the total area was quantitated.
Statistical analysis
All data were analyzed using Prism software (v 5.0a, GraphPad Prism Inc., San Diego, CA). ). A one--way ANOVA with Bonferroni's multiple comparison correction and t--test was used to compare treatments. A two--way ANOVA with Bonferroni's multiple comparison correction was used to compare the pain behaviour responses between treatments. A p--value of < 0.05 was considered significant. All data are presented as mean ± SEM.
